Notice2023-17398

National Institute of Allergy and Infectious Diseases; Notice of Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
August 14, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 155 (Monday, August 14, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 155 (Monday, August 14, 2023)]
[Notices]
[Pages 55054-55055]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-17398]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: <a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: September 11, 2023.
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Acting Director.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Grand Hall, 5601 
Fishers Lane, MD 20852 (Hybrid Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.

[[Page 55055]]

    Agenda: To review and evaluate grant applications
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Grand Hall, 5601 
Fishers Lane, MD 20852 (Hybrid Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD 20892-9834, 301-496-7291, 
<a href="/cdn-cgi/l/email-protection#2b5b444e40526b464a424705454243054c445d"><span class="__cf_email__" data-cfemail="c9b9a6aca2b089a4a8a0a5e7a7a0a1e7aea6bf">[email&#160;protected]</span></a>.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
    Date: September 11, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Terrace Room, 5601 
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Grand Hall, 5601 
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD 20892-9834, 301-496-7291, 
<a href="/cdn-cgi/l/email-protection#ee9e818b8597ae838f8782c0808786c0898198"><span class="__cf_email__" data-cfemail="a8d8c7cdc3d1e8c5c9c1c486c6c1c086cfc7de">[email&#160;protected]</span></a>.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Microbiology and Infectious Diseases Subcommittee.
    Date: September 11, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Garden 2, 5601 
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Garden 2, 5601 
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD, 20892-9834, 301-496-7291, 
<a href="/cdn-cgi/l/email-protection#14647b717f6d5479757d783a7a7d7c3a737b62"><span class="__cf_email__" data-cfemail="4a3a252f21330a272b232664242322642d253c">[email&#160;protected]</span></a>.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Immunology and Transplantation Subcommittee.
    Date: September 11, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Garden 1, 5601 
Fishers Lane, Rockville, MD 20852.
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Conference Room: Garden 1, 5601 
Fishers Lane, Rockville, MD 20852 (Hybrid Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892-9834 301-496-7291, <a href="/cdn-cgi/l/email-protection#4d3d222826340d202c242163232425632a223b"><span class="__cf_email__" data-cfemail="1969767c7260597478707537777071377e766f">[email&#160;protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: <a href="https://www.niaid.nih.gov/about/advisory-council">https://www.niaid.nih.gov/about/advisory-council</a>, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 9, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17398 Filed 8-11-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on August 14, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.